Blog
RSS FeedPosted by Michael Wonder on 01 Aug 2021
Family says choice is life in Australia or death waiting for PHARMAC
2 August 2021 - A Tauranga couple is splitting up their family so their daughter can access treatment for spinal muscular ...
Posted by Michael Wonder on 31 Jul 2021
New Zealand Pharmaceutical Schedule - 1 August 2021
1 August 2021 - The August 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Jul 2021
Cancer patients, advocates 'gobsmacked' PHARMAC declining funding application for life-changing drug
29 July 2021 - Ovarian cancer patients and advocates are "utterly gobsmacked" Pharmac has proposed to decline a funding application ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC releases drug wish-list to be more 'transparent' but advocates say it gives false hope
28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC commits to being more transparent
28 July 2021 - For the first time, PHARMAC is sharing its priority lists for all funding applications for medicines ...
Posted by Michael Wonder on 19 Jul 2021
PHARMAC ensuring supply of prednisolone to treat children with respiratory conditions
19 July 2021 - PHARMAC is working hard to ensure on-going supply of an important medicine used to treat respiratory conditions ...
Posted by Michael Wonder on 19 Jul 2021
Decision to fund rasagiline
16 July 2021 - PHARMAC is pleased to announce the decision to fund rasagiline (Azilect) a new treatment for people ...
Posted by Michael Wonder on 19 Jul 2021
Decision to widen access to rituximab for people with B-cell acute lymphoblastic leukaemia/lymphoma
9 July 2021 - PHARMAC is widening access to rituximab (Riximyo) to include treatment of people with newly diagnosed B-cell ...
Posted by Michael Wonder on 14 Jul 2021
No more sending Kiwis across the ditch as new national neuroendocrine cancer treatment service opens
14 July 2021 - The opening of a new multimillion dollar national service to treat neuroendocrine cancer means patients will ...
Posted by Michael Wonder on 14 Jul 2021
PM speaks about COVID-19, Fiji and PHARMAC funding
14 July 2021 - Prime Minister Jacinda Ardern spoke to media after a speech at the New Zealand Institute of International ...
Posted by Michael Wonder on 14 Jul 2021
PHARMAC 'cruel' for failing to fund drugs for rare illnesses — advocate
14 July 2021 - New Zealand’s drug-buying agency doesn’t value the lives of all people equally, according to those advocating for ...
Posted by Michael Wonder on 14 Jul 2021
PHARMAC has for decades refused to fund Synagis drug that could save vulnerable babies from RSV
14 July 2021 - Newshub can reveal after two decades of refusing to fund a drug that could halve the ...
Posted by Michael Wonder on 10 Jul 2021
Application for cystic fibrosis medicine received by PHARMAC
9 July 2021 - PHARMAC is starting its funding assessment process for a new cystic fibrosis medication after receiving an ...
Posted by Michael Wonder on 07 Jul 2021
Access to miracle drug Trikafta a 'lifeline' for cystic fibrosis patients with no other hope
7 July 2021 - A handful of cystic fibrosis patients have been thrown a lifeline with a drug company offering ...
Posted by Michael Wonder on 01 Jul 2021
PHARMAC is seeking views on declining funding applications
29 June 2021 - PHARMAC is considering declining 97 inactive medicine funding applications. ...